chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: FLU3
Symptoms: Influenza, Influenza B virus test positive, Influenza like illness, Influenza virus test positive, Seroconversion test positive
Clinical narrative: Initial literature report received on 01 Nov 2010: This patient with chronic obstructive pulmonary disease participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness (ILI) symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction (PCR) assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza (LCI). This patient had an antibody titer value of 5, 20, 20, and 80 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient, who had a history of COPD, had 4-fold increase in titer value and tested positive for seroconversion of B strain. Therefore this patient was considered as an LCI case of Influenza B. The outcome was not reported.
Sex: U
Vaccine: FLU3
Symptoms: Influenza, Influenza B virus test positive, Influenza virus test positive, Seroconversion test negative
Clinical narrative: Initial literature report received on 01 Nov 2010: This patient participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness (ILI) symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction (PCR) assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza (LCI). This patient had an antibody titer value of 453, 320, 320, and 640 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient did not had 4-fold increase in titer value and tested negative for seroconversion of B strain but tested positive for B strain PCR. Therefore this patient was considered as an LCI case of Influenza B. The outcome was not reported.
Sex: U
Vaccine: FLU3
Symptoms: Influenza, Influenza A virus test positive, Influenza virus test positive, Seroconversion test positive
Clinical narrative: Initial literature report received on 01 Nov 2010: This patient participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza. This patient had an antibody titer value of 5, 5, 5, and 80 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient had more than 4 fold increase in titer value and also tested positive for seroconversion of A/H3N2 strain. This patient was considered as an case of Influenza A/H3N2. The outcome was not reported.
Sex: U
Vaccine: RAB, RAB
Symptoms: Drug exposure during pregnancy, Hereditary disorder, Intra-uterine death
Clinical narrative: Initial report received from a nurse on 08 Nov 2010: The mother of this child was vaccinated with RABAVERT (batch number 460011A), (dose: 1ml) intramuscularly for pre-exposure prophylactic series on 27 Jul 2010. At the time of vaccination, the mother denied pregnancy. On 03 Aug 2010, the mother presented herself for second-dose of pre-exposure series and it had been found that the mother had not had a menstrual period for seven weeks. Pregnancy test performed on an unspecified date was positive see case (PHHY2010US51547). This child's mother did not use contraceptives and there was no family history reported. The mother had history of normal pregnancy in 2006 following in vitro fertilization procedure and had normal delivery on 13 Jan 2010. The foetus of the current pregnancy died at 4 weeks probably because of genetic reason. A dilation and curettage was used for removal.
Sex: U
Vaccine: RAB, RAB
Symptoms: Drug exposure during pregnancy, Intra-uterine death, Pregnancy test positive, Uterine dilation and curettage
Clinical narrative: Initial report received from a nurse on 08 Nov 2010: The mother of this child was vaccinated with RABAVERT (batch number 460011A), (dose: 1ml) intramuscularly for pre-exposure prophylactic series on 27 Jul 2010. At the time of vaccination, the mother denied pregnancy. On 03 Aug 2010, the mother presented herself for second-dose of pre-exposure series and it had been found that the mother had not had a menstrual period for seven weeks. Pregnancy test performed on an unspecified date was positive see case (PHHY2010US51547). This child's mother did not use contraceptives and there was no family history reported. The mother had history of normal pregnancy in 2006 following in vitro fertilization procedure and had normal delivery on 13 Jan 2010. The foetus of the current pregnancy died at 4 weeks probably because of genetic reason. A dilation and curettage was used for removal.
Sex: U
Vaccine: FLU3
Symptoms: Influenza, Influenza B virus test positive, Polymerase chain reaction, Seroconversion test negative
Clinical narrative: Initial literature report received on 01 Nov 2010: This patient with medical history of heart failure participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza. This patient, who had a history of heart failure, had an antibody titer value of 80, 80, 57, and 160 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient did not have 4-fold increase in titer value and tested negative for seroconversion but tested positive for PCR of B strain. Therefore this patient was considered as an LCI case of Influenza B. The outcome was not reported.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Feeling abnormal, Pyrexia, Rash generalised
Clinical narrative: Pt states she "didn't feel good" after vaccine then developed a fever and rash all over body.
Age: 58.0
Sex: F
Vaccine: HEP
Symptoms: Urticaria
Clinical narrative: Hives
Age: 57.0
Sex: M
Vaccine: PPV
Symptoms: Blood test normal, Brain scan normal, Injection site pain, Neck pain, Nuclear magnetic resonance imaging normal
Clinical narrative: Post PNEUMOVAX 23 shot felt pain down (L) arm that progressively got worse. Progressively got worse where it is now b/l arms and back of neck. Went to multiple neurologist. (-) MRI, (-) brain scan, (-) blood work. Questionable GBS.
Age: 57.0
Sex: M
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: Post PNEUMOVAX 23 shot felt pain down (L) arm that progressively got worse. Progressively got worse where it is now b/l arms and back of neck. Went to multiple neurologist. (-) MRI, (-) brain scan, (-) blood work. Questionable GBS.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Oedema peripheral, Pyrexia
Clinical narrative: Pain, arm swelled to 3 times size, but not where injection was given, fever between 99+99.9 (normal temp is usually 97.6).
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Injection site induration, Injection site swelling, Joint swelling
Clinical narrative: Left arm - injection site (L) deltoid became very firm but upper (L) chest above breast was swollen and pink as well as left upper shoulder and arm including elbow.
Age: 0.77
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Erythema, Induration
Clinical narrative: 1.5 x 1 cm area of redness with mild induration.
Age: 29.0
Sex: F
Vaccine: PPV
Symptoms: Diarrhoea, Gastrointestinal inflammation, Malaise, Rash
Clinical narrative: Received PNEUMOVAX 23 at a lesser dose of 0.5 mL at 1:30. At 3pm that day was generally not feeling well. On 10/5/10 at 0500 had diarrhea & at 2pm had a rash on her back. Went to E.R. was diagnosed with inflamed bowel. Given medication for diarrhea and BENADRYL for rash. Sent home.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Hyperhidrosis, Movement disorder, Muscle disorder, Viral infection
Clinical narrative: Profuse perspiration. Unable to move, no muscle control. Taken to emergency hospital. After 5 days of tests the final diagnosis was viral syndrome.
Age: 9.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Autopsy, Biopsy lung abnormal, Haemoglobin decreased, Immunohistochemistry, Influenza
Clinical narrative: A serious spontaneous report of wild-type H1N1 and streptococcal pneumoniae has been received from a physician concerning a nine-year-old female subsequent to H1N1, Intranasal. The patient's past medical history includes Down Syndrome, cardiac disease (unspecified), leukemia (in remission), cough and limp for several days prior to vaccination. The patient received INFLUENZA vaccine on 08-Oct-2009. The patient received H1N1, Intranasal on 08-Oct-2009. The physician received a report from the Vaccine Adverse Event Reporting System (VAERS) of a patient that died suddenly at home on 15-Oct-2009, seven days after vaccination. On the day of vaccination the patient's white blood cell count was 2, 500 micro liters and hemoglobin was 7.5 g/dL. Lung tissue specimens from an autopsy revealed growth of streptococcal pneumoniae and immunohistochemical and molecular evidence of wild-type H1N1 virus. Final autopsy results were pending. The outcome of the events was fatal with the date of death as 15-Oct-2009. Additional information was received on 19-Nov-2009 that included the following: The lot number of H1N1.
Age: 9.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Influenza A virus test positive, Pneumonia streptococcal, Streptococcus test positive, Sudden death, White blood cell count decreased
Clinical narrative: A serious spontaneous report of wild-type H1N1 and streptococcal pneumoniae has been received from a physician concerning a nine-year-old female subsequent to H1N1, Intranasal. The patient's past medical history includes Down Syndrome, cardiac disease (unspecified), leukemia (in remission), cough and limp for several days prior to vaccination. The patient received INFLUENZA vaccine on 08-Oct-2009. The patient received H1N1, Intranasal on 08-Oct-2009. The physician received a report from the Vaccine Adverse Event Reporting System (VAERS) of a patient that died suddenly at home on 15-Oct-2009, seven days after vaccination. On the day of vaccination the patient's white blood cell count was 2, 500 micro liters and hemoglobin was 7.5 g/dL. Lung tissue specimens from an autopsy revealed growth of streptococcal pneumoniae and immunohistochemical and molecular evidence of wild-type H1N1 virus. Final autopsy results were pending. The outcome of the events was fatal with the date of death as 15-Oct-2009. Additional information was received on 19-Nov-2009 that included the following: The lot number of H1N1.
Age: 35.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Autopsy, Blood culture positive, Death, Influenza like illness, Multi-organ failure
Clinical narrative: A serious spontaneous report of septic shock, streptococca pneumoniae, multiorgan failure, respiratory distress and influenza like symptoms has been received from the Center for Disease Control (CDC) concerning a 35-year-old female subsequent to H1N1, Intranasal. The patient's medical history included hereditary spherocytosis, splenectomy and pneumococcal vaccination status was unknown. The patient received INFLUENZA vaccine on 09-Oct-2009. The patient received the H1N1, Intranasal on 22-Oct-2009. Per the CDC report on 24-Oct-2009, two days following the vaccination of H1N1, Intranasal the patient had influenza like symptoms. She arrived to the hospital in respiratory distress and multiorgan failure. The patient died with a diagnosis of septic shock and streptococca pneumoniae was isolated on blood culture. Lung tissue for a preliminary autopsy showed evidence of pneumococcal infection but no evidence of wild or vaccine strain 2009 H1N1. The outcome of the events was fatal. Additional information was received on 19-Nov-2009 that included the following: Lot number for H1N1 and VAERS report number.
Age: 35.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Pneumococcal infection, Pneumonia streptococcal, Respiratory distress, Septic shock, Streptococcus test positive
Clinical narrative: A serious spontaneous report of septic shock, streptococca pneumoniae, multiorgan failure, respiratory distress and influenza like symptoms has been received from the Center for Disease Control (CDC) concerning a 35-year-old female subsequent to H1N1, Intranasal. The patient's medical history included hereditary spherocytosis, splenectomy and pneumococcal vaccination status was unknown. The patient received INFLUENZA vaccine on 09-Oct-2009. The patient received the H1N1, Intranasal on 22-Oct-2009. Per the CDC report on 24-Oct-2009, two days following the vaccination of H1N1, Intranasal the patient had influenza like symptoms. She arrived to the hospital in respiratory distress and multiorgan failure. The patient died with a diagnosis of septic shock and streptococca pneumoniae was isolated on blood culture. Lung tissue for a preliminary autopsy showed evidence of pneumococcal infection but no evidence of wild or vaccine strain 2009 H1N1. The outcome of the events was fatal. Additional information was received on 19-Nov-2009 that included the following: Lot number for H1N1 and VAERS report number.
Age: 18.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Cardiac arrest, Cardiomegaly, Chest X-ray abnormal, Death, Resuscitation
Clinical narrative: A serious spontaneous report of fatal sudden cardiac arrest has been received from a healthcare professional from the Centers for Disease Control using information from the Vaccine Adverse Event Reporting System concerning a 18-year-old male, subsequent to H1N1 Monovalent Vaccine, Live, Intranasal. The patient's past medical history included dental care for gingivitis on 29-Oct-2009. There were no concomitant medications reported. The patient received H1N1 Monovalent Vaccine, Live, Intranasal on 03-Nov-2009. On 03-Nov-2009 at 12:45 PM the patient received the vaccination, on an unreported time the same day, the subject suffered a sudden cardiac arrest and CPR was initiated. A chest X-ray was performed and showed an enlarged heart with no pulmonary effusion. The patient was pronounced dead at 11:30 PM on 03-Nov-2009. The event resulted in a fatal outcome.
Age: 60.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: CSF protein increased, CSF white blood cell count negative, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: Without any warning, onset of unexpected and unexplained paralysis and numbness started at bottom of feet and ascended to waist in less than two hours.
Age: 60.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Nerve conduction studies abnormal, Nuclear magnetic resonance imaging normal, Paraesthesia
Clinical narrative: Without any warning, onset of unexpected and unexplained paralysis and numbness started at bottom of feet and ascended to waist in less than two hours.
Age: 60.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Electromyogram, Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Nerve conduction studies
Clinical narrative: Without any warning, onset of unexpected and unexplained paralysis and numbness started at bottom of feet and ascended to waist in less than two hours.
Age: 60.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Nuclear magnetic resonance imaging
Clinical narrative: Without any warning, onset of unexpected and unexplained paralysis and numbness started at bottom of feet and ascended to waist in less than two hours.
Age: 0.85
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Blood glucose increased, Cardiac arrest, Death, Endotracheal intubation, Gastrointestinal tube insertion
Clinical narrative: Initial report received on 10 November 2010 from a nurse, who also provided the following day a copy of the VAERS report (temporary VAERS number E-49458) that was submitted by the reporter. A previously healthy 10-month-old male, who had pre-existing medical condition of diaper rash, died after receiving a first intramuscular right leg injection of FLUZONE SV 2010-2011 (lot number U3744AA) on 08 November 2010 at 09:15 AM. That evening after the patient had received the vaccination, at around 21:00 PM, the mother called the emergency medical system (EMS). Details of what occurred prior to the EMS arrival to the apartment are unknown. One report is that the baby was in the bath with an older sibling, or mom was in the bathroom with another child, heard something in another room and then went and found the baby unresponsive. The mother started Cardiopulmonary resuscitation (CPR). It was 5-10 minutes before the fire department arrived and continued CPR, the EMS then arrived and found the baby on the floor with vomitis in his hair, and they continued CPR and intubated the patient. They were unsuccessful in placing an intravenous line and epinephrine was administered via endotracheal tube. Upon arrival to the emergency room, the patient was unresponsive, asystolic with no pulse and no respirations. Circulatory and respiratory failure were also reported. An intravenous line was started and 3 rounds of epinephrine and atropine were administered via the intravenous line and one dose of Na Bicarb. The endotracheal tube was removed and another one places as well as a nasogastric tube. All attempts to revive the patient were unsuccessful and the patient was pronounced dead at 10:48 PM the same day. The medical examiner was handling the case. At the time of this report, investigation by coroner and police were pending. Documents held by sender: None
Age: 0.85
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Pulse absent, Respiration abnormal, Resuscitation, Unresponsive to stimuli, Vomiting
Clinical narrative: Initial report received on 10 November 2010 from a nurse, who also provided the following day a copy of the VAERS report (temporary VAERS number E-49458) that was submitted by the reporter. A previously healthy 10-month-old male, who had pre-existing medical condition of diaper rash, died after receiving a first intramuscular right leg injection of FLUZONE SV 2010-2011 (lot number U3744AA) on 08 November 2010 at 09:15 AM. That evening after the patient had received the vaccination, at around 21:00 PM, the mother called the emergency medical system (EMS). Details of what occurred prior to the EMS arrival to the apartment are unknown. One report is that the baby was in the bath with an older sibling, or mom was in the bathroom with another child, heard something in another room and then went and found the baby unresponsive. The mother started Cardiopulmonary resuscitation (CPR). It was 5-10 minutes before the fire department arrived and continued CPR, the EMS then arrived and found the baby on the floor with vomitis in his hair, and they continued CPR and intubated the patient. They were unsuccessful in placing an intravenous line and epinephrine was administered via endotracheal tube. Upon arrival to the emergency room, the patient was unresponsive, asystolic with no pulse and no respirations. Circulatory and respiratory failure were also reported. An intravenous line was started and 3 rounds of epinephrine and atropine were administered via the intravenous line and one dose of Na Bicarb. The endotracheal tube was removed and another one places as well as a nasogastric tube. All attempts to revive the patient were unsuccessful and the patient was pronounced dead at 10:48 PM the same day. The medical examiner was handling the case. At the time of this report, investigation by coroner and police were pending. Documents held by sender: None
Age: 0.85
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Cardiac arrest, Circulatory collapse, Death, Endotracheal intubation, Gastrointestinal tube insertion
Clinical narrative: Initial report received on 10 November 2010 from a nurse, who also provided the following day a copy of the VAERS report (temporary VAERS number E-49458) that was submitted by the reporter. A previously healthy 10-month-old male, who had pre-existing medical condition of diaper rash, died after receiving a first intramuscular right leg injection of FLUZONE SV 2010-2011 (lot number U3744AA) on 08 November 2010 at 09:15 AM. That evening after the patient had received the vaccination, at around 21:00 PM, the mother called the emergency medical system (EMS). Details of what occurred prior to the EMS arrival to the apartment are unknown. One report is that the baby was in the bath with an older sibling, or mom was in the bathroom with another child, heard something in another room and then went and found the baby unresponsive. The mother started Cardiopulmonary resuscitation (CPR). It was 5-10 minutes before the fire department arrived and continued CPR, the EMS then arrived and found the baby on the floor with vomitis in his hair, and they continued CPR and intubated the patient. They were unsuccessful in placing an intravenous line and epinephrine was administered via endotracheal tube. Upon arrival to the emergency room, the patient was unresponsive, asystolic with no pulse and no respirations. Circulatory and respiratory failure were also reported. An intravenous line was started and 3 rounds of epinephrine and atropine were administered via the intravenous line and one dose of Na Bicarb. The endotracheal tube was removed and another one places as well as a nasogastric tube. All attempts to revive the patient were unsuccessful and the patient was pronounced dead at 10:48 PM the same day. The medical examiner was handling the case. At the time of this report, investigation by coroner and police were pending. Documents held by sender: None
Age: 0.85
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Pulse absent, Respiratory arrest, Respiratory failure, Resuscitation, Unresponsive to stimuli
Clinical narrative: Initial report received on 10 November 2010 from a nurse, who also provided the following day a copy of the VAERS report (temporary VAERS number E-49458) that was submitted by the reporter. A previously healthy 10-month-old male, who had pre-existing medical condition of diaper rash, died after receiving a first intramuscular right leg injection of FLUZONE SV 2010-2011 (lot number U3744AA) on 08 November 2010 at 09:15 AM. That evening after the patient had received the vaccination, at around 21:00 PM, the mother called the emergency medical system (EMS). Details of what occurred prior to the EMS arrival to the apartment are unknown. One report is that the baby was in the bath with an older sibling, or mom was in the bathroom with another child, heard something in another room and then went and found the baby unresponsive. The mother started Cardiopulmonary resuscitation (CPR). It was 5-10 minutes before the fire department arrived and continued CPR, the EMS then arrived and found the baby on the floor with vomitis in his hair, and they continued CPR and intubated the patient. They were unsuccessful in placing an intravenous line and epinephrine was administered via endotracheal tube. Upon arrival to the emergency room, the patient was unresponsive, asystolic with no pulse and no respirations. Circulatory and respiratory failure were also reported. An intravenous line was started and 3 rounds of epinephrine and atropine were administered via the intravenous line and one dose of Na Bicarb. The endotracheal tube was removed and another one places as well as a nasogastric tube. All attempts to revive the patient were unsuccessful and the patient was pronounced dead at 10:48 PM the same day. The medical examiner was handling the case. At the time of this report, investigation by coroner and police were pending. Documents held by sender: None
Age: 0.85
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Vomiting
Clinical narrative: Initial report received on 10 November 2010 from a nurse, who also provided the following day a copy of the VAERS report (temporary VAERS number E-49458) that was submitted by the reporter. A previously healthy 10-month-old male, who had pre-existing medical condition of diaper rash, died after receiving a first intramuscular right leg injection of FLUZONE SV 2010-2011 (lot number U3744AA) on 08 November 2010 at 09:15 AM. That evening after the patient had received the vaccination, at around 21:00 PM, the mother called the emergency medical system (EMS). Details of what occurred prior to the EMS arrival to the apartment are unknown. One report is that the baby was in the bath with an older sibling, or mom was in the bathroom with another child, heard something in another room and then went and found the baby unresponsive. The mother started Cardiopulmonary resuscitation (CPR). It was 5-10 minutes before the fire department arrived and continued CPR, the EMS then arrived and found the baby on the floor with vomitis in his hair, and they continued CPR and intubated the patient. They were unsuccessful in placing an intravenous line and epinephrine was administered via endotracheal tube. Upon arrival to the emergency room, the patient was unresponsive, asystolic with no pulse and no respirations. Circulatory and respiratory failure were also reported. An intravenous line was started and 3 rounds of epinephrine and atropine were administered via the intravenous line and one dose of Na Bicarb. The endotracheal tube was removed and another one places as well as a nasogastric tube. All attempts to revive the patient were unsuccessful and the patient was pronounced dead at 10:48 PM the same day. The medical examiner was handling the case. At the time of this report, investigation by coroner and police were pending. Documents held by sender: None
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Rash
Clinical narrative: rash, fever- administered Tylenol, Motrin
Age: 2.0
Sex: M
Vaccine: FLUN3
Symptoms: Decreased appetite, Insomnia, Lethargy, Nasal congestion, Pyrexia
Clinical narrative: fever, loss of appetite, nasal congestion, lethargy, difficulty sleeping
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Blood pressure increased, Chills, Depressed level of consciousness, Dyspnoea, Feeling abnormal
Clinical narrative: Yesterday morning I got a flu shot. My first time getting one. By late afternoon I felt like I was getting ill. By 6pm I felt awful. I went to lay down, before I could make it into bed I got the "chills" and started shaking so badly it sent my glasses flying off my face  halfway across the room. I got into bed to try to warm up, still shivering and shaking more like convulsions. It became hard to breathe, I was short of breath. When my wife came into the room she tried to get me to go to the hospital. I was dazed and sort of semi-conscious. I kept saying "I'll be ok, I can't get up now." She called 911 and paramedics arrived. By that time I was not aware of what was happening. They "hooked me up" to their equipment and ran me through the tests. I had a fever and my blood pressure was up. It did not seem life-threatening, so I convinced them to leave me in bed (I HATE hospitals) and if anythying happened or got worse we'd go straight there (1/2mi. away.) Woke up at 2PM today, still feeling awful, but on the mend. Coincidence? I don't think so. Anyway that is my experience...
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Malaise, Pyrexia, Tremor
Clinical narrative: Yesterday morning I got a flu shot. My first time getting one. By late afternoon I felt like I was getting ill. By 6pm I felt awful. I went to lay down, before I could make it into bed I got the "chills" and started shaking so badly it sent my glasses flying off my face  halfway across the room. I got into bed to try to warm up, still shivering and shaking more like convulsions. It became hard to breathe, I was short of breath. When my wife came into the room she tried to get me to go to the hospital. I was dazed and sort of semi-conscious. I kept saying "I'll be ok, I can't get up now." She called 911 and paramedics arrived. By that time I was not aware of what was happening. They "hooked me up" to their equipment and ran me through the tests. I had a fever and my blood pressure was up. It did not seem life-threatening, so I convinced them to leave me in bed (I HATE hospitals) and if anythying happened or got worse we'd go straight there (1/2mi. away.) Woke up at 2PM today, still feeling awful, but on the mend. Coincidence? I don't think so. Anyway that is my experience...
Age: 43.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Drug exposure during pregnancy, Hereditary disorder, Intra-uterine death
Clinical narrative: Initial report received from a health care professional (nurse) on 03 Aug 2010: This patient was vaccinated with RABAVERT (rabies virus vaccine, batch number 460011A), (dose: 1ml) intramuscularly for pre-exposure prophylactic series on 27 Jul 2010.  At the time of vaccination, the patient denied pregnancy.  On 03 Aug 2010, the patient presented herself for second- dose of the pre-exposure series and it had been found that the patient had not had a menstrual period for seven weeks.  Pregnancy test performed on an unspecified date was positive.  Follow-up received on 13 Oct 2010: Multiple attempts were made to collect additional information and outcome of event without success.  This case is considered lost to follow up.  Follow up report received from nurse on 08 Nov 2010: It was reported that the patient did not use contraceptives.  No family history was reported.  The patient had history of normal pregnancy in 2006 following in vitro fertilization procedure and had normal delivery on 13 Jan 2010.  No prenatal tests were done for this pregnancy.  It was reported that the fetus of the current pregnancy died at 4 weeks probably because of genetic reason (see case: PHHY2010US76704).  A dilation and curettage procedure was performed.
Age: 43.0
Sex: F
Vaccine: RAB, RAB
Symptoms: Drug exposure during pregnancy, Intra-uterine death, Pregnancy test positive, Uterine dilation and curettage
Clinical narrative: Initial report received from a health care professional (nurse) on 03 Aug 2010: This patient was vaccinated with RABAVERT (rabies virus vaccine, batch number 460011A), (dose: 1ml) intramuscularly for pre-exposure prophylactic series on 27 Jul 2010.  At the time of vaccination, the patient denied pregnancy.  On 03 Aug 2010, the patient presented herself for second- dose of the pre-exposure series and it had been found that the patient had not had a menstrual period for seven weeks.  Pregnancy test performed on an unspecified date was positive.  Follow-up received on 13 Oct 2010: Multiple attempts were made to collect additional information and outcome of event without success.  This case is considered lost to follow up.  Follow up report received from nurse on 08 Nov 2010: It was reported that the patient did not use contraceptives.  No family history was reported.  The patient had history of normal pregnancy in 2006 following in vitro fertilization procedure and had normal delivery on 13 Jan 2010.  No prenatal tests were done for this pregnancy.  It was reported that the fetus of the current pregnancy died at 4 weeks probably because of genetic reason (see case: PHHY2010US76704).  A dilation and curettage procedure was performed.
Age: 46.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Pyrexia
Clinical narrative: Pt. was afebrile prior to receiving this vaccine. Pt complained of feeling chills and feverish shortly after midnight following the vaccine. Pt also had a surgical procedure done prior to the vaccine which may have also caused fever.
Age: 1.14
Sex: F
Vaccine: FLUX
Symptoms: Chills, Crying, Nervousness, Pain, Pyrexia
Clinical narrative: Woke up crying, chills (shaky), achy, and with fever of 103.9F
Age: 8.0
Sex: M
Vaccine: FLUN(H1N1)
Symptoms: Choking, Increased upper airway secretion, Oropharyngeal pain, Pyrexia
Clinical narrative: Sore Throat, Fever (100 degrees), choking on phlegm
Age: 4.0
Sex: F
Vaccine: DTAP, HIBV, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: injection site redness, swelling, itching and hot to touch on right leg
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Keloid scar, Pruritus, Skin irritation
Clinical narrative: Keloid formation, Itching / Irritation
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Pain
Clinical narrative: Pain in left arm where I received the shot. Pain when I lift my arm. Pain still persists now (11/16/2010)
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Rash
Clinical narrative: 48 hours later noted red patch at bandage site.  Mid injection point was clear.  Rash (fine red)- not uticaria spread to shoulder.  Pt taking laratadine and using topical cortisone.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Vision blurred, Vomiting
Clinical narrative: vomittng, vision blury, numbness in both arms and legs. Patient was refered to urgent care, Doctor, or Emergency Room. Pateint went to see her Doctor, but do not know the out come
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Local reaction
Clinical narrative: rash developed 24 hrs post admin, developed zoster-like vesicles 48hrs post. admin with extended area of redness surrounding rash. Advised pt. to apply cold compresses, take diphenhydramine if needed. Pt later, from different advice from another health care practitioner applied hot compresses, condition seemed to worsen. Pt made appt with PCP 96 hrs post admin. PCP determined local reaction, continue cold compresses.
Age: 41.0
Sex: M
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site haematoma
Clinical narrative: Hematoma to right shoulder circled with redness. It happened immediately, EMT Was Called and patient did recover. NO other information given regarding patients recovery.
Age: 57.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Herpes zoster, Oropharyngeal pain, Rash, Rash pruritic
Clinical narrative: This is from where the member started doing his onw VAERS report:  Flu shot taken approx. 1400 hours Sat 6 Nov 2010, at 1800 hours noticed soar throat pains. Sunday 0800 hours 7 Nov 2010 noticed visible rash on chest and under right arm(itchy rash). Reported to sick call 0730 Tues 9 Nov 2010 and diagnosed with Shingles per the physician Dr. Memeber reported to the clinic on the 15th for some medication to aid in his recovery. Member reported to the Medical Office today at 10 AM stating what has occuered since drilll.  //SIGNED//  Public Health Technician
Age: 57.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Herpes zoster, Oropharyngeal pain, Rash pruritic
Clinical narrative: This is from where the member started doing his onw VAERS report:  Flu shot taken approx. 1400 hours Sat 6 Nov 2010, at 1800 hours noticed soar throat pains. Sunday 0800 hours 7 Nov 2010 noticed visible rash on chest and under right arm(itchy rash). Reported to sick call 0730 Tues 9 Nov 2010 and diagnosed with Shingles per the physician Dr. Memeber reported to the clinic on the 15th for some medication to aid in his recovery. Member reported to the Medical Office today at 10 AM stating what has occuered since drilll.  //SIGNED//  Public Health Technician
Age: 21.0
Sex: M
Vaccine: TYP
Symptoms: Asthenia, Chills, Dysphagia, Headache, Oropharyngeal pain
Clinical narrative: Patient reported with chief complaint of weakness with chills, headache, throat pain with swallowing, head pain with movement. Symptoms not life threatening. Released fit for full duty.
Age: 21.0
Sex: M
Vaccine: TYP
Symptoms: Pain
Clinical narrative: Patient reported with chief complaint of weakness with chills, headache, throat pain with swallowing, head pain with movement. Symptoms not life threatening. Released fit for full duty.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Right arm hurts dwon to her fingers. Arm has been very sore for three days. Patient did go see her Dr. on 10/21/2010 and gave her a cortisone shot in the area of the injection site. Will see Dr. agin in three weeks or to call if not better will do an EMG if not improved. Patient was going to go see the orthopedic on 11/11/2010 and will call back when she know more. Patient has not called back with results.
Age: 4.0
Sex: F
Vaccine: FLUN3
Symptoms: Cough, Decreased appetite, Lethargy, Pyrexia, Vomiting
Clinical narrative: Fever  Coughing lethergy The next morning no appetite and vomiting X 3 later. Fever x 4 days
Age: 10.0
Sex: M
Vaccine: FLUX, HEPA
Symptoms: Pallor, Palpitations, Pyrexia, Tremor, Vomiting
Clinical narrative: shaking, high fever (103), throwing up, heart racing, paleness
Age: 6.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Oedema, Pain in extremity
Clinical narrative: Red patch approximately 4" long near injection site; significant edema, soreness in left arm (per mother's report).
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Local reaction, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Large local reaction at vaccine site. 6.5 x 7 cm erythema and swelling on left upper arm.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Colonoscopy, Endoscopy, Fatigue, Haemoglobin decreased
Clinical narrative: Off work since 10/22/10. I received my flu shot 10/13/10. Became very fatigued that day. On 10/22/10 to Dr for sinus infection. On 10/29/10 to Dr sinus infection worse - 2 series of antibiotics. Hemoglobin 9.2 on 10/29/10 - to 6th Dr 11/1/10 (put on iron). Having colonoscopy and endoscopy on 11/9/10. Still very fatigued.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Sinusitis
Clinical narrative: Off work since 10/22/10. I received my flu shot 10/13/10. Became very fatigued that day. On 10/22/10 to Dr for sinus infection. On 10/29/10 to Dr sinus infection worse - 2 series of antibiotics. Hemoglobin 9.2 on 10/29/10 - to 6th Dr 11/1/10 (put on iron). Having colonoscopy and endoscopy on 11/9/10. Still very fatigued.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Muscle spasms, Nausea, Somnolence
Clinical narrative: Muscle spasms arms, legs, face - 3 hrs nausea weakness falls asleep most of the time.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Exfoliative rash
Clinical narrative: 1 week after administration pt came down with small, raised, flesh-colored scaly bumps on all joints - fingers, toes... & worse on knees & elbows. Not painful, non-pruritic. Just very unsightly!
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Body temperature increased, Erythema, Injection site erythema, Injection site pain, Lymphadenopathy
Clinical narrative: Severe pain/erythema over deltoid/biceps axillary adenopathy. T-99.4 Rx'd ROCEPHIN 1gm & AUGMENTIN 875 mg BID x 10 d 11/6/10 - to ER, increased redness, Rx'd IV Vancomycin, added BACTRIM D.S. 1 BID.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: White blood cell count increased
Clinical narrative: Severe pain/erythema over deltoid/biceps axillary adenopathy. T-99.4 Rx'd ROCEPHIN 1gm & AUGMENTIN 875 mg BID x 10 d 11/6/10 - to ER, increased redness, Rx'd IV Vancomycin, added BACTRIM D.S. 1 BID.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Chest discomfort, Nasal congestion, Wheezing
Clinical narrative: Flu shot 1 - 10:30A - 11 AM. 530 - 6PM Nasal congestion, mild N, chest tightness, wheezing mild - reminded him of Asthma that he had up until age 30. Tx with hot tea & ASA. Said wheezing lasted about 2 hr. Otherwise sx lasted not > 1 1/2 da.
Age: 63.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site rash, Injection site swelling, Pyrexia
Clinical narrative: 48 hours after vaccination in right arm - Pt developed rash, swelling, low grade fever, & sore arm. Rash is approximately 4 inches in diameter.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Patient received vaccine at 2:51 pm on 11/3/10. She experience severe fever, chills, and sweating during the late evening while attempting to sleep. She also suffered from severe head pain, aches, and overall weakness. She is feeling better today but remains tired.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Pyrexia
Clinical narrative: Patient received vaccine at 2:51 pm on 11/3/10. She experience severe fever, chills, and sweating during the late evening while attempting to sleep. She also suffered from severe head pain, aches, and overall weakness. She is feeling better today but remains tired.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: Sore throat, cough, glands swelled.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left arm swollen from shoulder to elbow, redness, painful.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Dizziness, Feeling hot, Injection site movement impairment, Nausea, Oedema peripheral
Clinical narrative: On 9/8/10 I got my pneumonia shot, that evening I had extreme difficulty in moving my arm. During the night I became dizzy and nauseous and extremely hot. The following day my arm became hot and swollen that evening I went to urgent care. I was treated with steroids and antibiotics.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Skin warm
Clinical narrative: On 9/8/10 I got my pneumonia shot, that evening I had extreme difficulty in moving my arm. During the night I became dizzy and nauseous and extremely hot. The following day my arm became hot and swollen that evening I went to urgent care. I was treated with steroids and antibiotics.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Swelling, redness, warm to touch.
Age: 7.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Swelling, redness, warm to touch.
Age: 71.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: Patient's left arm was swollen, red and warm to touch. Patient received a PNEUMOVAX injection in left arm. Patient was told to apply cold compact and see MD if not better.
Age: 16.0
Sex: F
Vaccine: FLUN3
Symptoms: Blood glucose normal, Grand mal convulsion, Syncope
Clinical narrative: Vasovagal faint and brief (< 30 secs) tonic-clonic seizure blood glucose = 94.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Bronchial hyperreactivity, Decreased appetite, Dyspnoea, Musculoskeletal stiffness, Myalgia
Clinical narrative: Within 8 hrs of receiving vaccine my throat became real sore, then developed low grade fever & muscle aches later that evening. Next day, the 6th & 7th had fever of 103 degrees with bad muscle aches, loss of appetite and continued sore throat with neck stiffness. Also had trouble with deep inspiration but was not short of breath. On the 8th fever continued so went to local PCP who dx reactive airway disease and was placed on prednisone 40mg x 5 days and albuterol inhaler.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Within 8 hrs of receiving vaccine my throat became real sore, then developed low grade fever & muscle aches later that evening. Next day, the 6th & 7th had fever of 103 degrees with bad muscle aches, loss of appetite and continued sore throat with neck stiffness. Also had trouble with deep inspiration but was not short of breath. On the 8th fever continued so went to local PCP who dx reactive airway disease and was placed on prednisone 40mg x 5 days and albuterol inhaler.
Age: 86.0
Sex: M
Vaccine: PPV
Symptoms: Asthma, Cardiac failure congestive, Chest X-ray, Cough, Dyspnoea
Clinical narrative: Information has been received from a consumer concerning an 86 (also reported as 88) year old male who in approximately 2007 "about 2-3 years ago" was vaccinated with a first dose of PNEUMOVAX 23 (route and lot # invalid). On 06-OCT-2010 the patient went to his HCP for a respiratory illness and was placed on amoxicillin. On 10-OCT-2010 the patient received a flu shot at church (manufacturer unknown). On 21-OCT-2010 the patient received a chest x-ray and electrocardiogram from HCP (result unknown) and received a second dose of PNEUMOVAX 23 (route and lot # invalid). On 22-OCT-2010 the patient had trouble breathing, felt cold, no fever reported. On 23-OCT-2010 to 24-OCT-2010 the patient experienced foot and joint swelling. On 21-OCT-2010 to 25-OCT-2010 the patient reported 8-10 pound weight gain. On 25-OCT-2010 nurse practitioner sent patient to the emergency room. The patient was admitted to the ICU with diagnoses of congestive heart failure and fluid retention. On 29-OCT-2010 to 30-OCT-2010 was further diagnosed with pneumonia. The patient was discharged to home with medications for asthma, diuretics and antibiotics. On 04-NOV-2010 the patient continued with persistent cough labored breathing and wheezing. Fluid retention resolved. At the time of this report, the patient's outcome was not recovered. Congestive heart failure, pneumonia and fluid retention were considered to be other important medical events by the reporter. Additional information has been requested. The patient was hospitalized.